Xcout Intel
Novocure competitors & alternatives
The 12 closest competitors and alternatives to Novocure among biotechnology companies — ranked by similarity to what Novocure actually does, not by market-cap band.
Subscribe to see Novocure’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Novocure
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development of therapies using Tumor Treating Fields.
Novocure at a glance
Novocure is a biotechnology company headquartered in Jersey. It is publicly listed (NVCR) with a market capitalisation of $1.8B. Xcout tracks 18 named people at Novocure, including Frank Leonard (Chief Executive Officer & Director). Xcout recorded 2 job postings from Novocure in the last 90 days.
Novocure leadership
- Frank LeonardChief Executive Officer & Director
- Mukund ParavasthuChief Operating Officer
- Christoph BrackmannChief Financial Officer
- Uri WeinbergChief Innovation Officer & Chief Medical Officer
- Michael PuriChief Human Resources Officer
- William F. DoyleExecutive Chairman
12 more named people on record for Novocure, with roles, board committees and tenure — see the full roster →
Hiring at Novocure
Xcout recorded 2 job postings from Novocure in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Novocure's hiring signals →
Top 12 Novocure competitors
Ranked by semantic similarity — how close each company is to Novocure by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Haniva Technology LLC is a biotechnology company that develops patented combination therapies and drug delivery devices to treat various forms of cancer. Its research focuses on using non-thermal plasma alongside hypoxia-activated DNA-damaging agents to selectively target and reduce tumor volume, prevent metastasis, and serve as an adjuvant treatment following tumor resection.
Biotech
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California.
Similar biotechnology company
Kortuc Inc. develops cancer radiotherapy solutions, specifically offering an innovative radiosensitizer designed to eliminate tumor hypoxia and maximize the effectiveness of radiation treatment. The company serves the medical and oncology research sectors by advancing clinical trials and expanding treatment options for cancer patients.
Similar biotechnology company
KAIO Therapy, LLC develops an Immune Activating Heat Therapy (IAHT) technology designed to treat cancer patients by combining hyperthermia with immunotherapy. The system utilizes injected nanoparticles and an alternating magnetic field device to induce controlled heat within tumors, which destroys cancer cells and activates the patient's immune system against primary and metastatic tumors.
Similar biotechnology company
Oleander Medical Technologies is developing a cancer treatment called Targeted Osmotic Lysis (TOL), which destroys malignant cells by forcing them to absorb excessive sodium and burst. The therapy combines an existing heart medication with an investigational pulsed electric field device to target cancers with elevated sodium channel expression while leaving healthy cells unharmed.
Biotechnology / Medtech
Kuros Biosciences AG is a Swiss-headquartered biotech company, listed on the SIX Swiss Exchange. The company focuses on growing bone with products like MagnetOs Bone Graft.
Pharmaceuticals
Johnson & Johnson researches, develops, and delivers innovative medicines, therapies, and medical technology devices. The company focuses on healthcare areas such as oncology, neuroscience, immunology, cardiovascular diseases, orthopaedics, and surgery to serve patients globally.
Similar biotechnology company
Revolution Medicines is a clinical-stage oncology company that develops novel targeted therapies to outsmart cancer. The company focuses on discovering and advancing therapeutic pipelines for patients with difficult-to-treat tumors.
Similar biotechnology company
Celyad Oncology is a biopharmaceutical company headquartered in Mont-Saint-Guibert, Belgium, focused on the development of innovative therapies.
Biotech
BioNTech is a global immunotherapy company that researches and develops mRNA vaccines and other treatments for cancer and infectious diseases. The company serves patients, healthcare professionals, and researchers by advancing scientific innovations into clinical therapies.
Biotech
Northwest Biotherapeutics, Inc. (NWBO) is a biotechnology firm that creates personalized immune-based treatments for various cancers, operating both within the United States and internationally. Their product pipeline relies on DCVax, a proprietary technology platform. This platform harnesses a patient's own activated dendritic cells to stimulate their immune system to combat cancerous cells. The company's leading therapeutic candidate, DCVax-L, has successfully completed Phase III clinical trials targeting Glioblastoma multiforme, an aggressive form of brain cancer. Additionally, Northwest Biotherapeutics is progressing DCVax-Direct through Phase I/II clinical studies, focusing on the treatment of inoperable solid tumors. Founded in 1996, the company's headquarters are situated in Bethesda, Maryland.
Similar biotechnology company
Affimed Therapeutics is a biotechnology company focused on developing cancer immunotherapies that recruit and activate innate immune cells, particularly natural killer (NK) cells, to attack tumor cells. Its investigational products are intended for oncology patients and are developed for use by cancer-care providers.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Novocure and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Novocureand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →